Related Experiment Videos
Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link
U Piemontino1, A Ceriello, G Di Minno
1Clinica Medica, Università degli Studi di Napoli, Italy.
Insights
Diabetic patients face high thrombotic risks due to hemostatic abnormalities. Further research is needed to confirm the link between metabolic control and thrombosis prevention in diabetes mellitus.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Hematology
Background:
- Diabetes mellitus significantly increases the risk of major thrombotic complications, such as stroke and myocardial infarction, with up to 80% of patients succumbing to these conditions.
- Abnormalities in plasma and cellular components of the hemostatic system are frequently observed in diabetic patients, potentially contributing to their heightened thrombosis risk.
Purpose of the Study:
- To critically review existing literature on the relationship between hemostatic abnormalities and metabolic control in diabetes mellitus.
- To identify gaps in knowledge regarding hemostatic parameters in different diabetes types and in the presence of coexisting metabolic derangements.
Main Methods:
- A critical review of specialized literature was conducted.
- Data from clinical studies were analyzed to assess the link between hemostatic abnormalities and metabolic control.
Main Results:
- The association between hemostatic and metabolic abnormalities in diabetes mellitus is currently considered circumstantial.
- Limited information exists on the differences in hemostatic parameters between type I and type II diabetes mellitus.
- Understanding of how combined glucose and lipid abnormalities affect the hemostatic system in diabetics is restricted.
Conclusions:
- Further dedicated studies are essential to elucidate the precise relationship between hemostatic function and metabolic control in diabetes.
- Clarifying the extent to which optimal metabolic control mitigates thrombosis risk in diabetes mellitus is a critical research priority.
Background:
As many as 80% of diabetic patients die from major thrombotic complications of atherosclerosis, stroke and myocardial infarction. Plasma and cellular components of the hemostatic system are often abnormal in diabetic patients, and some of these abnormalities may play a role in the high risk of thrombosis in these patients.
Materials And Methods:
Clinical studies imply that certain hemostatic abnormalities of diabetic patients are related, to some extent, to poor metabolic control. Thus, a critical review of the data available in the specialized literature has been carried out.
Results:
Although suggestive, the link between hemostatic and metabolic abnormalities in diabetes mellitus is only circumstantial. Little is known about similarities and differences between type I and type II diabetes mellitus with respect to hemostatic parameters. Likewise, current understanding of the effects on the hemostatic system of the combination of glucose and lipid abnormalities often coexisting in diabetic patients is rather limited.
Conclusions:
Ad hoc studies are mandatory to clarify unsolved issues in this field and define the extent to which good metabolic control is crucial to preventing the risk of thrombosis in diabetes mellitus.